Fundraising FoxNew Rhein Healthcare Investors, LLC — 2018 Investments
1 investments dated 2018 · listed companies and verified rows first · show all
Neuraptive Therapeuticsneuraptive.comin𝕏Dec 2018 · $11.5M✓ verified
Neuraptive is a biotechnology company staffed by professionals with expertise in research and development, manufacturing, and commercialization in the pharmaceutical industry.
BiotechDeep TechHealthtechMedical DevicesLouisville, US
David Jackson(Executive Officer, Director)Gino DiSciullo(Director)Randy Hubbell(Director)
Board seatGreg ParekhIvan Gergel· per SEC Form D
Co-investorsCentral Texas Angel Network
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.